Literature DB >> 28601847

Incidence of irritable bowel syndrome and chronic fatigue following GI infection: a population-level study using routinely collected claims data.

Ewan Donnachie1, Antonius Schneider2, Michael Mehring2, Paul Enck3.   

Abstract

OBJECTIVES: To investigate the occurrence of postinfectious IBS in routine outpatient care, comparing different types of GI infection and its interaction with psychosomatic comorbidity.
DESIGN: Retrospective cohort study using routinely collected claims data covering statutorily insured patients in Bavaria, Germany. Cases were defined as patients without prior record of functional intestinal disorder with a first-time diagnosis of GI infection between January 2005 and December 2013 and classed according to the type of infection. Each case was matched by age, sex and district of residence to a patient without history of GI infection. Prior psychological disorder (depression, anxiety or stress reaction disorder) was assessed in the 2 years prior to inclusion. Proportional hazards regression models were used to estimate the HRs for GI infection and psychological disorder. Chronic fatigue syndrome (CFS) was assessed as a comparator outcome.
RESULTS: A total of 508 278 patients with first diagnosis of GI infection were identified, resulting in a matched cohort of 1 016 556 patients. All infection types were associated with an increased risk of IBS (HR: 2.19-4.25) and CFS (HR 1.35-1.82). Prior psychological disorder was a distinct risk factor for IBS (HR: 1.73) and CFS (HR: 2.08). Female sex was a further risk factor for both conditions.
CONCLUSION: Psychological disorder and GI infections are distinct risk factors for IBS. The high incidence of non-specific GI infection suggests that postinfectious IBS is a common clinical occurrence in primary care. Chronic fatigue is a further significant sequela of GI infection. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  biopsychosocial model; chronic fatigue syndrome; irritable bowel syndrome; postinfectious syndrome

Mesh:

Year:  2017        PMID: 28601847     DOI: 10.1136/gutjnl-2017-313713

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  17 in total

1.  The Prevalence, Comorbidity, Management and Costs of Irritable Bowel Syndrome.

Authors:  Winfried Häuser; Ursula Marschall; Peter Layer; Thomas Grobe
Journal:  Dtsch Arztebl Int       Date:  2019-07-08       Impact factor: 5.594

2.  [Calculation of the prevalence of progressive muscular atrophy among adults in China based on urban medical insurance data from 15 provinces].

Authors:  L Xu; L Chen; D S Fan; J N Feng; L L Liu; S Y Zhan; S F Wang
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2020-06-18

3.  Self-help guidebook improved quality of life for patients with irritable bowel syndrome.

Authors:  Antonius Schneider; Stefanie Rosenberger; Johanna Bobardt; Jessica Bungartz-Catak; Oxana Atmann; Bernhard Haller; Anne Kennedy; Paul Enck
Journal:  PLoS One       Date:  2017-07-25       Impact factor: 3.240

4.  Epidemiological and clinical factors associated with post-exertional malaise severity in patients with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Alaa Ghali; Paul Richa; Carole Lacout; Aline Gury; Anne-Berengere Beucher; Chadi Homedan; Christian Lavigne; Geoffrey Urbanski
Journal:  J Transl Med       Date:  2020-06-22       Impact factor: 5.531

5.  Patients With Somatoform Disorders Are Prone to Expensive and Potentially Harmful Medical Procedures—Results of a Retrospective Cohort Study Over 15 Years.

Authors:  Antonius Schneider; Ewan Donnachie; Stephan Zipfel; Paul Enck
Journal:  Dtsch Arztebl Int       Date:  2021-06-25       Impact factor: 5.594

6.  Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study.

Authors:  Daniele Noviello; Andrea Costantino; Antonio Muscatello; Alessandra Bandera; Dario Consonni; Maurizio Vecchi; Guido Basilisco
Journal:  Neurogastroenterol Motil       Date:  2021-06-01       Impact factor: 3.960

Review 7.  Fatigue as the Chief Complaint–Epidemiology, Causes, Diagnosis, and Treatment.

Authors:  Peter Maisel; Erika Baum; Norbert Donner-Banzhoff
Journal:  Dtsch Arztebl Int       Date:  2021-08-23       Impact factor: 8.251

8.  The Natural History of Chronic Unexplained Gastrointestinal Disorders and Gastroesophageal Reflux During 20 Years: A US Population-Based Study.

Authors:  Rok Seon Choung; Yuri A Saito; Cathy D Schleck; William S Harmsen; Alan R Zinsmeister; Joseph A Murray; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2021-03       Impact factor: 11.104

Review 9.  Pediatric chronic fatigue syndrome: current perspectives.

Authors:  Esther Crawley
Journal:  Pediatric Health Med Ther       Date:  2018-03-29

Review 10.  The Evolving Role of Gut Microbiota in the Management of Irritable Bowel Syndrome: An Overview of the Current Knowledge.

Authors:  Amir Mari; Fadi Abu Baker; Mahmud Mahamid; Wisam Sbeit; Tawfik Khoury
Journal:  J Clin Med       Date:  2020-03-04       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.